CARLSBAD, Calif., Oct. 18, 2023 /PRNewswire/ -- Emerging as a leading platform in healthcare AI and data analytics, Limmi announced today a significant collaboration with Vinergy Capital to transform healthcare operations management. Under the terms of the agreement, Vinergy will acquire up to 4% of the equity stock of Limmi in consideration for up to $862,500 in cash, and license IP from Limmi in exchange for equity stock in Vinergy Capital.

加利福尼亚州卡尔斯巴德，2023年10月18日/PRNewswire/-作为医疗保健AI和数据分析的领先平台，Limmi今天宣布与Vinergy Capital进行重大合作，以改变医疗保健运营管理。根据协议条款，Vinergy将收购Limmi股权的4%，以现金支付高达862500美元，并从Limmi许可IP以换取Vinergy Capital的股权。

Details of the transaction can be found in Vinergy's press release here. This partnership will allow Vinergy's keystone investment, Healthcare Accretion AI, to harness Limmi's state-of-the-art AI platform to scale and optimize their AI models focused on streamlining healthcare clinic operations, as Healthcare Accretion AI launches services into the trillion-dollar healthcare market..

交易细节可以在Vinergy的新闻稿中找到。这种合作关系将使Vinergy的keystone投资Healthcare Accretion AI能够利用Limmi最先进的AI平台来扩展和优化他们的AI模型，重点是简化医疗保健诊所的运营，因为医疗保健Accretion AI将服务启动到数万亿美元的医疗保健市场。。

The healthcare landscape is riddled with complex, fragmented, and sensitive patient health data. Traditional data and analysis platforms can struggle to deal with both the complexity and security requirements that this data necessitates. Limmi's FDA and HIPAA compliant data platform is designed from the ground up for health data, allowing Healthcare Accretion AI to process vast amounts of data at unprecedented speeds.

医疗保健领域充斥着复杂，分散和敏感的患者健康数据。传统的数据和分析平台可能难以处理这些数据所需的复杂性和安全性要求。Limmi的FDA和HIPAA兼容数据平台是从地面上为健康数据设计的，允许医疗认证AI以前所未有的速度处理大量数据。

The combination of Limmi and Healthcare Accretion AI technology provides advanced data analytics that help physicians and healthcare administrators improve resource management, lower overhead, and improve patient outcomes..

Limmi和医疗保健认证AI技术的结合提供了先进的数据分析，帮助医生和医疗保健管理员改善资源管理，降低开销并改善患者结果。。

'Limmi's technology stands out as a game-changer, allowing us to rapidly improve healthcare operations by delivering cutting edge data analytics on an FDA and HIPAA compliant platform,' said Michael Dalsin, Chair of Healthcare Accretion AI, Vinergy's keystone investment. 'I am pleased Vinergy made this important and strategic investment as it can scale our proprietary trained models across healthcare facilities in the United States, a trillion-dollar market.'.

Vinergy's keystone investment的healthcare Accretion AI主席Michael Dalsin说：“Limmi的技术脱颖而出，改变了游戏规则，使我们能够通过在符合FDA和HIPAA的平台上提供尖端的数据分析来快速改善医疗保健运营。”我很高兴Vinergy做出了这项重要的战略投资，因为它可以在美国医疗机构，一万亿美元的市场中扩展我们专有的训练有素的模型。

Bryan Ivory, CTO of Limmi, shared, 'This collaboration is a testament to the transformative power of AI in the healthcare world. We are excited to support Healthcare Accretion AI and Vinergy in their quest to transform how healthcare operations are managed in the US, leading to lower physician burnout, improved patient outcomes, and greater efficiency in clinical operations.'.

Limmi的首席技术官Bryan Ivory分享说：“这种合作证明了人工智能在医疗保健领域的变革力量。我们很高兴支持医疗保健认证AI和Vinergy寻求改变美国医疗保健业务的管理方式，从而降低医生职业倦怠，改善患者预后，提高临床操作效率。

The deal reinforces Limmi's commitment to bringing the transformative power of AI to healthcare and life sciences. As Vinergy leverages Limmi's technology to power their investments' AI capabilities, the broader healthcare ecosystem stands to benefit from more strategic and informed capital and resource allocation..

该协议加强了Limmi致力于将人工智能的变革力量带入医疗保健和生命科学。随着Vinergy利用Limmi技术为其投资的AI功能提供动力，更广泛的医疗保健生态系统将受益于更具战略性和知情性的资本和资源分配。。

SOURCE Limmi

来源限制